Form 8-K - Current report:
SEC Accession No. 0001171843-25-002027
Filing Date
2025-04-04
Accepted
2025-04-04 16:20:14
Documents
17
Period of Report
2025-04-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_040325.htm   iXBRL 8-K 25714
2 EXHIBIT 10.1 exh_101.htm EX-10.1 57195
3 PRESS RELEASE exh_991.htm EX-99.1 6874
4 logo.jpg GRAPHIC 3189
  Complete submission text file 0001171843-25-002027.txt   313985

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3003
6 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25598
7 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
8 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
20 EXTRACTED XBRL INSTANCE DOCUMENT f8k_040325_htm.xml XML 3157
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 25815032
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)